NACDS Offers Solutions to Congressional Committee Examining Healthcare Costs
PBM reform, access to pharmacist services, and value-based care are among the recommendations to the Health Subcommittee of the House Energy and Commerce Committee.
PBM reform, access to pharmacist services, and value-based care are among the recommendations to the Health Subcommittee of the House Energy and Commerce Committee.
NACDS is applauding the Senators for sending a letter urging the Federal Trade Commission to “complete its investigation into the health care industry’s most powerful prescription drug middlemen.”
Employers moving on from dominant PBMs to save costs demonstrates the need for Congress to stand up for Medicare and Medicaid, too.
NACDS continues to urge the U.S. Congress to finish the job – and enact the bipartisan PBM reforms that Congress has advanced in the 118th Congress. A January 19 Inside Health Policy article quotes NACDS on the topic.
NACDS' new TV ad says the “clock is ticking” for vital Medicare and Medicaid reforms needed to protect Americans, communities, and their pharmacies.
A letter released by CMS today states: “We urge plans and PBMs to engage in sustainable and fair practices with all pharmacies – not just pharmacies owned by PBMs – and we are closely monitoring plan compliance with CMS network adequacy standards and other requirements.”
House passage of Lower Costs, More Transparency Act includes important aspects of PBM reform in the Medicaid program; demonstrates the strong bipartisan commitment that exists to confront the harmful PBM tactics that threaten people and the pharmacies serving them.
Among key progress, 41 states now permanently allow pharmacy technicians to vaccinate – up from 14 states in September 2021
Looking ahead to 2024, NACDS remains well positioned through its focus on its true identity. NACDS is the membership, and NACDS executes aggressively on the collective and collaborative will of the membership.
NACDS continues to call for urgent enactment of real PBM reform, which at the federal level must include Americans on Medicare and Medicaid and their pharmacies.